Dr Liz Dallimore on the exciting times ahead for Argenica Therapeutics as they fast track Phase 2
MAKING MONEY MATTER: Biotech companies have not been top of investors minds recently but I was excited to speak with Dr Liz Dallimore of Argenica Therapeutics (ASX:AGN) who are moving from Phase 1 to Phase 2 trials. Since we last spoke there has been a steady increase in the share price as they work on a drug to reduce brain damage after strokes as well as other brain injuries.TIME STAMPS:00:00 intro02:00 Background to Argenica Therapeutics (asx:AGN) and what sets them apart04:30 Phase 1 and Phase 2 trials and the outcomes from the trials06:50 The competition08:30 The recent placement and use of funds going forward12:00 The importance of the FDA approval and the market in the USA14:30 Timelines for the phase 2 trials and any challenges?18:00 Progress with the FDA21:00 Current valuation and milestones ahead and future partners23:30 The other applications for the company going forward26:30 Three reasons to sit up and take notice right now
- Forums
- ASX - By Stock
- AGN
- AGN Media thread
AGN Media thread, page-89
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
83.5¢ |
Change
-0.025(2.91%) |
Mkt cap ! $103.2M |
Open | High | Low | Value | Volume |
87.0¢ | 87.0¢ | 82.0¢ | $107.3K | 128.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6891 | 83.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.0¢ | 7770 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6891 | 0.835 |
1 | 25000 | 0.830 |
1 | 6054 | 0.825 |
2 | 6163 | 0.820 |
2 | 16882 | 0.815 |
Price($) | Vol. | No. |
---|---|---|
0.860 | 7770 | 1 |
0.865 | 619 | 1 |
0.870 | 9699 | 1 |
0.885 | 15100 | 1 |
0.890 | 24022 | 2 |
Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |